Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer

(2013) Christopher R. Friese et al.   BREAST CANCER RESEARCH AND TREATMENT

Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients

(2012) Sayed H. Naderi et al.   AMERICAN JOURNAL OF MEDICINE

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

(2012) Caitlin C. Murphy et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

(2012) James L. Khatcheressian et al.   JOURNAL OF CLINICAL ONCOLOGY

Patient-Centered Care for Older Adults with Multiple Chronic Conditions: A Stepwise Approach from the American Geriatrics Society

(2012)   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

(2012) Christina Davies et al.   LANCET

Patient-Reported Discontinuation of Endocrine Therapy and Related Adverse Effects Among Women With Early-Stage Breast Cancer

(2012) Erin J. Aiello Bowles et al.   Journal of Oncology Practice

Statin Discontinuation in High-Risk Patients: A Systematic Review of the Evidence

(2011) Yessica-Haydee Gomez Sandoval et al.   CURRENT PHARMACEUTICAL DESIGN

Single-Pill vs Free-Equivalent Combination Therapies for Hypertension: A Meta-Analysis of Health Care Costs and Adherence

(2011) Beth Sherrill et al.   Journal of Clinical Hypertension

Role of Nonclinical Factors in the Receipt of High-Quality Systemic Adjuvant Breast Cancer Treatment

(2011) Jennifer J. Griggs   JOURNAL OF CLINICAL ONCOLOGY

Influence of Race, Insurance, Socioeconomic Status, and Hospital Type on Receipt of Guideline-Concordant Adjuvant Systemic Therapy for Locoregional Breast Cancers

(2011) Xiao-Cheng Wu et al.   JOURNAL OF CLINICAL ONCOLOGY

Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability

(2011) Richard N Shiffman et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors

(2010) Tina W. F. Yen et al.   CANCER

The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review

(2010) N. Muszbek et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

(2010) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   Journal of Oncology Practice

Effect of Statin Adherence on Cerebrovascular Disease in Primary Prevention

(2009) Sylvie Perreault et al.   AMERICAN JOURNAL OF MEDICINE

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17

(2008) J. N. Ingle et al.   ANNALS OF ONCOLOGY

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial

(2008) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY